AI Article Synopsis
Article Abstract
Polytrauma commonly involves concussion (mild traumatic brain injury [mTBI]) and peripheral trauma including limb fractures. Interactions between mTBI and peripheral injuries are poorly understood, both leading to chronic pain and neurobehavioral impairments. To elucidate these interactions, a murine polytrauma model was developed. mTBI alone resulted in similar increased mechanical allodynia in male and female mice. Female fracture and polytrauma groups displayed greater increases in hind paw tactile hypersensitivity for weeks after injury than did the respective male groups. Capsaicin-evoked spontaneous pain behaviors were greater in fracture and polytrauma female mice compared with male mice. The mTBI and polytrauma male mice displayed significant deficits in spatial working memory. All fracture, mTBI, or polytrauma groups had deficits in object recognition memory. Only male mTBI or polytrauma mice showed greater agitation and increased risk-taking behavior in open field testing as well as zero maze tests. Additionally, impaired diffuse noxious inhibitory control was observed in all mTBI and polytrauma mice. The model presented offers clinically relevant features useful for studying persistent pain as well as cognitive and other behavioral changes after TBI including polytrauma. A better understanding of nervous system dysfunction after TBI and polytrauma might help prevent or reduce persistent pain and disability in these patients. PERSPECTIVE: The polytrauma model presented has relevant features of chronic pain and neurobehavioral impairments useful for studying mechanisms involved in their development. This model may have special value in understanding altered descending pain modulation after TBI and polytrauma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jpain.2018.06.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Design and methodology of a randomized clinical trial of quetiapine to reduce central nervous system polypharmacy in veterans with postconcussive syndrome symptoms.
Contemp Clin Trials
December 2024
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Article Synopsis
- * This clinical trial aims to compare quetiapine monotherapy against treatment as usual (TAU) to see if it offers better recovery from postconcussive syndrome and PTSD symptoms in veterans undergoing rehabilitation for mTBI.
- * The study will enroll 146 veterans over 12 weeks, focusing on outcomes like symptom reduction, functional disability, and quality of life, with the goal of determining if quetiapine can enhance recovery and improve overall well-being.
Small Molecule Drug C381 Attenuates Brain Vascular Damage Following Repetitive Mild Traumatic Injury.
Neurotrauma Rep
October 2024
Palo Alto Veterans Institute for Research, VA Palo Alto Health Care System, Palo Alto, California, USA.
Traumatic brain injury (TBI) remains a significant public health concern, with no effective therapeutic interventions to ameliorate the enduring consequences. The prevailing understanding of TBI pathophysiology indicates a central role for vascular dysfunction. Transforming growth factor-β (TGF-β) is a multifunctional cytokine crucial for vascular development.
View Article and Find Full Text PDFChronic headaches after traumatic brain injury: Diagnostic complexity associated with increased cost.
NeuroRehabilitation
November 2024
Veterans Affairs Salt Lake City Health Care System, Informatics Decision Enhancement and Analytic Sciences Center of Innovation, Salt Lake City, UT, USA.
Article Synopsis
- Chronic headaches are a common issue for military Veterans after experiencing traumatic brain injuries (TBI), and their treatment is often complicated and costly.
- A study of 141,125 Veterans post-9/11 revealed that those with specific types of headache combinations, especially post-TBI migraines, faced significantly higher healthcare costs.
- There's a need for further research to understand if the high costs correlate with better treatment results or indicate persistent, harder-to-treat headaches.
Risk factors for traumatic intracranial hemorrhage in mild traumatic brain injury patients at the emergency department: a systematic review and meta-analysis.
Scand J Trauma Resusc Emerg Med
September 2024
Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Article Synopsis
- Mild traumatic brain injury (mTBI) is a common reason for people to go to the emergency room, but only a few of those cases have serious brain bleeding problems called traumatic intracranial hemorrhage (tICH).
- The goal of this study was to find out which factors might put people with mTBI at risk for tICH, to help doctors improve how they make decisions in the emergency room.
- They looked at information from 17 studies with over 26,000 patients and found that signs like a skull fracture, low consciousness, and loss of awareness were strong reasons to check for tICH, while other common symptoms weren’t as effective at predicting it.
CCL5 is essential for axonogenesis and neuronal restoration after brain injury.
J Biomed Sci
September 2024
Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institute, Taipei, 11031, Taiwan.
Article Synopsis
- Traumatic brain injury (TBI) can hurt connections in the brain, making it hard for people to move and feel properly. CCL5 is a protein that may help protect the brain and support healing.
- Scientists tested CCL5 on mice with mild brain injuries to see if it could improve their movement and feeling abilities.
- The results showed that using CCL5 helped the injured mice's brains recover better, fixing important connections and supporting growth in their brain cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!